NCT06297083View on ClinicalTrials.gov

Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Peanut Allergy
Interventions
DRUG

Peanut Oral Powder [PEANUT POWDER]

Peanut oral immunotherapy at varying doses and build-up regimes given daily for 18 months

DIETARY_SUPPLEMENT

Probiotic (LGG®, Lactobacillus Rhamnosus) or placebo probiotic (maltodextrin)

Probiotic or placebo-probiotic given daily for 18 months

Sponsors
All Listed Sponsors
lead

Murdoch Childrens Research Institute

OTHER

NCT06297083 - Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy | Biotech Hunter | Biotech Hunter